Shkreli: Price Increase Has Stuck, Happy With That
61 بار بازدید -
8 سال پیش
-
Dec.23 -- Former Turing Pharmaceuticals
Dec.23 -- Former Turing Pharmaceuticals CEO Martin Shkreli discusses the controversy surrounding Daraprim pricing and his outlook for the pharmaceutical industry. He speaks on "Bloomberg Daybreak: Americas."
8 سال پیش
در تاریخ 1395/10/09 منتشر شده
است.
61
بـار بازدید شده